Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

The following table presents the Company’s revenues disaggregated by geographical region and revenue type ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Total
Year ended December 31, 2023:
Geographical region:
North America(a)	$	2,454	$	2,999	$	4,508	$	9,961
Western Europe	2,407		1,519		1,542		5,468
Other developed markets(b)	329		510		431		1,270
High-growth markets(c)	1,982		2,113		3,096		7,191
Total	$	7,172	$	7,141	$	9,577	$	23,890

Revenue type:
Recurring	$	5,897	$	4,360	$	8,425	$	18,682
Nonrecurring	1,275		2,781		1,152		5,208
Total	$	7,172	$	7,141	$	9,577	$	23,890

Year ended December 31, 2022:
Geographical region:
North America(a)	$	3,054	$	3,154	$	5,522	$	11,730
Western Europe	2,645		1,377		1,837		5,859
Other developed markets(b)	358		506		481		1,345
High-growth markets(c)	2,701		1,999		3,009		7,709
Total	$	8,758	$	7,036	$	10,849	$	26,643

Revenue type:
Recurring	$	6,958	$	4,220	$	9,698	$	20,876
Nonrecurring	1,800		2,816		1,151		5,767
Total	$	8,758	$	7,036	$	10,849	$	26,643

Year ended December 31, 2021:
Geographical region:
North America(a)	$	2,899	$	2,534	$	4,365	$	9,798
Western Europe	2,497		1,540		1,840		5,877
Other developed markets(b)	368		508		481		1,357
High-growth markets(c)	2,806		1,806		3,158		7,770
Total	$	8,570	$	6,388	$	9,844	$	24,802

Revenue type:
Recurring	$	6,772	$	3,756	$	8,607	$	19,135
Nonrecurring	1,798		2,632		1,237		5,667
Total	$	8,570	$	6,388	$	9,844	$	24,802

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as Japan, Australia and New Zealand.

(c) The Company defines high-growth markets as developing markets of the world experiencing accelerated growth, over extended periods, in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.